AAFA Advocates in Action on Capitol Hill

A group of AAFA advocates visited Capitol Hill to call on Congress to take action on important priorities for people with asthma and allergies.

The group held 28 meetings with key members of congressional staff. They talked about the following priorities:

• Funding the National Asthma Control Program (NACP) - AAFA is calling for $40 million to fund this program that currently helps people with asthma in 23 states, Puerto Rico, and the City of Houston.
• Passing the Elijah E. Cummings Family Asthma Act (H.R. 5749) - This bill would expand the NACP to all 50 states. The bill directs the CDC to work with state and local health departments to give out information and teach the public about asthma. It would also require states to make plans to address asthma, especially for communities bearing the highest burden of asthma.
• Supporting the Healthy at Home Act (S.2834/H.R. 5533) - Healthy housing is crucial for people with asthma because the home environment can significantly impact respiratory health. This bill would provide federal funding to help building owners make needed changes to improve air quality for tenants.
• Dillon’s Law (S.3575/H.R. 3910) - Dillon's Law is a bipartisan bill that offers incentives to states if they allow trained people to carry and give epinephrine in an emergency. It also requires that these people be protected from civil liability for giving someone epinephrine. Epinephrine is the first-line treatment for a serious and potentially life-threatening allergic reaction known as anaphylaxis.

New EPA Standards Will Help Improve Air Quality

Your Support Makes a Difference

People can manage asthma with appropriate treatment. Education on asthma basics, treatments, and triggers helps people understand and manage their conditions, and can even save and improve lives. AAFA advocates for laws that would give more people the tools they need to control asthma.

Together, we can help people breathe easier.

RESEARCH NEWS

Here's the latest asthma and allergy research news:

Allergy

• New Research on the Relationship Between Air Pollution and the Development of Allergic Disease
• Sublingual Tablet Immunotherapy Improves Quality of Life in Adults with Allergic Rhinoconjunctivitis

• Maternal Stressful Life Events During Pregnancy and Childhood Asthma and Wheeze
• Health Care Costs and Use in Children with Difficult-to-Control Asthma Treated with Biologic Therapies
• Asthma Control and Associated Risk Factors Among Adults with Current Asthma

 
To learn more about this month’s asthma and allergy news, visit our blog.

CLINICAL TRIALS

Are You Currently Taking Oral Corticosteroids (OCS) for Your Asthma?

Would you like to contribute to important new research? SUNRISE is a clinical study investigating whether a new biologic treatment called tezepelumab may help to reduce or remove the need for OCS in adults with severe asthma. The study is looking for people who:

• Are between 18 and 80 years of age
• Have had an asthma diagnosis for at least 1 year
• Have been taking OCS for asthma for at least 6 months
• Have been using inhaled corticosteroids for at least a year, and a long-acting beta 2-agonist (LABA) for at least 3 months
• Have not been receiving any biologic treatment for asthma for at least 4 months

Sponsored by AstraZeneca
 

LEARN MORE

SURVEYS

Participants Needed for Project on Young Adults with Asthma

• Be between the ages of 18 and 25
• Have a confirmed asthma diagnosis

CME OPPORTUNITY

Seeking Control for Moderate-to-Severe Asthma

Did You Miss Our Previous Issue?

Check out our most recent issue for news on the EPIPEN Act, brand name vs. generic medicines, and more. 

                                   READ THE LATEST ISSUE

Thank you for your continued support.
Visit aafa.org and kidswithfoodallergies.org